• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDICEM TECHNOLOGY S.R.O. DILAPAN-S; Dilator, cervical, synthetic, osmotic

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDICEM TECHNOLOGY S.R.O. DILAPAN-S; Dilator, cervical, synthetic, osmotic Back to Search Results
Device Problem No Apparent Adverse Event (3189)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 12/14/2022
Event Type  Injury  
Event Description
The patient indicated for iol (induction of labour) using dilapan-s.The patient - gravida 2, parity 1, 37+6 weeks gestation, previous instrumental delivery with forceps, induced for iol for pre-eclampsia - on 200mg labetalol bd, raised bmi 39.4 rods were inserted on (b)(6)2022 as part of induction process, the rods were inserted for 15 hours.On (b)(6) 2022 the hcp (health care professional) attempted to remove the rods on vaginal examination but they were not able to locate the rods in cervix or vagina.Both a speculum and digital examination were unable to locate any dilators in situ.Transabdominal and a transvaginal uss were performed and they were unable to locate the rods with either scan (possible retraction into the uterus is mentioned).Further attempt to remove rods via speculum and vaginal examination was unsucessful.Rods remained in situ and the patient was transferred to delivery suite for monitoring and continuation of induction procedure.The patient was given the option of continuing her induction or opting for cs (caesarean section).It was discussed that as she wasn't in established labour, she would need second stage cervical ripening to induce contractions and that the consultant was unsure how the potential retained rods would impact her and the baby when the contractions started.The same day on (b)(6) 2022 evening the hcp (after discussion and obtaining the patient's consent) decided to perform cs instead of continuing in induction.The missing rods were supposed to be removed during cs (as confirmed with the facility during a consultation).Later it was confirmed with the mri scan obtained on (b)(6) 2022 that excluded the presence of the dilators in situ.Both patient and the baby are fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DILAPAN-S
Type of Device
Dilator, cervical, synthetic, osmotic
Manufacturer (Section D)
MEDICEM TECHNOLOGY S.R.O.
karlovarska trida 20
kamenne zehrovice, 27301
EZ  27301
Manufacturer Contact
jan waclav
karlovarska trida 20
kamenne zehrovice, 27301
EZ   27301
MDR Report Key16002704
MDR Text Key305685354
Report Number3003994796-2022-00002
Device Sequence Number1
Product Code PKN
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K143447
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Other
Type of Report Initial
Report Date 12/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received12/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-